127 related articles for article (PubMed ID: 31633788)
1. Letter to the Editor: "Adrenalectomy Completely Cured Hypertension in Familial Hyperaldosteronism Type I Patients with Somatic KCNJ5 Mutation".
Almeida MQ
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 31633788
[No Abstract] [Full Text] [Related]
2. Response to Letter to the Editor: "Adrenalectomy Completely Cured Hypertension in Familial Hyperaldosteronism Type I Patients with Somatic KCNJ5 Mutation".
Lin YF; Peng KY; Chang CH; Hu YH; Wu VC; Chueh JS
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 31634403
[No Abstract] [Full Text] [Related]
3. Adrenalectomy Completely Cured Hypertension in Patients With Familial Hyperaldosteronism Type I Who Had Somatic KCNJ5 Mutation.
Lin YF; Peng KY; Chang CH; Hu YH; Wu VC; Chueh JS; Wu KD
J Clin Endocrinol Metab; 2019 Nov; 104(11):5462-5466. PubMed ID: 31287546
[TBL] [Abstract][Full Text] [Related]
4. KCNJ5 Somatic Mutation Is a Predictor of Hypertension Remission After Adrenalectomy for Unilateral Primary Aldosteronism.
Vilela LAP; Rassi-Cruz M; Guimaraes AG; Moises CCS; Freitas TC; Alencar NP; Petenuci J; Goldbaum TS; Maciel AAW; Pereira MAA; Silva GV; Pio-Abreu A; Zerbini MCN; Cavalcante ACBS; Carnevale FC; Pilan B; Yamauchi F; Srougi V; Tanno FY; Chambo JL; Latronico AC; Mendonca BB; Fragoso MCBV; Bortolotto LA; Drager LF; Almeida MQ
J Clin Endocrinol Metab; 2019 Oct; 104(10):4695-4702. PubMed ID: 31216002
[TBL] [Abstract][Full Text] [Related]
5. Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism.
Ip JC; Pang TC; Pon CK; Zhao JT; Sywak MS; Gill AJ; Soon PS; Sidhu SB
ANZ J Surg; 2015 Apr; 85(4):279-83. PubMed ID: 24274318
[TBL] [Abstract][Full Text] [Related]
6. Familial hyperaldosteronism type III a novel case and review of literature.
Pons Fernández N; Moreno F; Morata J; Moriano A; León S; De Mingo C; Zuñiga Á; Calvo F
Rev Endocr Metab Disord; 2019 Mar; 20(1):27-36. PubMed ID: 30569443
[TBL] [Abstract][Full Text] [Related]
7. Mosaicism for KCNJ5 Causing Early-Onset Primary Aldosteronism due to Bilateral Adrenocortical Hyperplasia.
Maria AG; Suzuki M; Berthon A; Kamilaris C; Demidowich A; Lack J; Zilbermint M; Hannah-Shmouni F; Faucz FR; Stratakis CA
Am J Hypertens; 2020 Feb; 33(2):124-130. PubMed ID: 31637427
[TBL] [Abstract][Full Text] [Related]
8. KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism.
Rossi GP; Cesari M; Letizia C; Seccia TM; Cicala MV; Zinnamosca L; Kuppusamy M; Mareso S; Sciomer S; Iacobone M; Mantero F; Pessina AC
J Hypertens; 2014 Jul; 32(7):1514-21; discussion 1522. PubMed ID: 24759126
[TBL] [Abstract][Full Text] [Related]
9. Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: a population-based study from Western Norway.
Arnesen T; Glomnes N; Strømsøy S; Knappskog S; Heie A; Akslen LA; Grytaas M; Varhaug JE; Gimm O; Brauckhoff M
Langenbecks Arch Surg; 2013 Aug; 398(6):869-74. PubMed ID: 23778974
[TBL] [Abstract][Full Text] [Related]
10. Mutations in KCNJ5 gene cause hyperaldosteronism.
Zennaro MC; Jeunemaitre X
Circ Res; 2011 Jun; 108(12):1417-8. PubMed ID: 21659651
[No Abstract] [Full Text] [Related]
11. [Primary aldosteronism: new insights into familial forms].
van den Meiracker AH; van der Linde AA; Claahsen van der Grinten HL; Danser AH; Deinum J
Ned Tijdschr Geneeskd; 2015; 159():A8932. PubMed ID: 26420144
[TBL] [Abstract][Full Text] [Related]
12. KCNJ5 mutation is a predictor for recovery of endothelial function after adrenalectomy in patients with aldosterone-producing adenoma.
Kishimoto S; Oki K; Maruhashi T; Kajikawa M; Mizobuchi A; Harada T; Yamaji T; Hashimoto Y; Yoshimura K; Nakano Y; Goto C; Yusoff FM; Nakashima A; Higashi Y
Hypertens Res; 2023 Sep; 46(9):2213-2227. PubMed ID: 37463983
[TBL] [Abstract][Full Text] [Related]
13. KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma.
Kitamoto T; Omura M; Suematsu S; Saito J; Nishikawa T
J Hypertens; 2018 Mar; 36(3):619-627. PubMed ID: 29016532
[TBL] [Abstract][Full Text] [Related]
14. KCNJ5 mutations in familial and non-familial primary aldosteronism.
Al-Salameh A
Eur J Endocrinol; 2024 Jun; 190(6):L9-L10. PubMed ID: 38781451
[No Abstract] [Full Text] [Related]
15. A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension.
Charmandari E; Sertedaki A; Kino T; Merakou C; Hoffman DA; Hatch MM; Hurt DE; Lin L; Xekouki P; Stratakis CA; Chrousos GP
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1532-9. PubMed ID: 22628607
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes.
Wu VC; Wang SM; Chueh SJ; Yang SY; Huang KH; Lin YH; Wang JJ; Connolly R; Hu YH; Gomez-Sanchez CE; Peng KY; Wu KD
Sci Rep; 2017 Jan; 7():39121. PubMed ID: 28102204
[TBL] [Abstract][Full Text] [Related]
17. Arterial stiffness and blood pressure improvement in aldosterone-producing adenoma harboring KCNJ5 mutations after adrenalectomy.
Chang CH; Hu YH; Tsai YC; Wu CH; Wang SM; Lin LY; Lin YH; Satoh F; Wu KD; Wu VC
Oncotarget; 2017 May; 8(18):29984-29995. PubMed ID: 28415786
[TBL] [Abstract][Full Text] [Related]
18. Familial hyperaldosteronism type III.
Monticone S; Tetti M; Burrello J; Buffolo F; De Giovanni R; Veglio F; Williams TA; Mulatero P
J Hum Hypertens; 2017 Dec; 31(12):776-781. PubMed ID: 28447626
[TBL] [Abstract][Full Text] [Related]
19. Genetic variations in the KCNJ5 gene in primary aldosteronism patients from Xinjiang, China.
Li NF; Li HJ; Zhang DL; Zhang JH; Yao XG; Wang HM; Abulikemu S; Zhou KM; Zhang XY
PLoS One; 2013; 8(1):e54051. PubMed ID: 23382865
[TBL] [Abstract][Full Text] [Related]
20. Somatic and inherited mutations in primary aldosteronism.
Fernandes-Rosa FL; Boulkroun S; Zennaro MC
J Mol Endocrinol; 2017 Jul; 59(1):R47-R63. PubMed ID: 28400483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
